OSCR
Get informed when a big investor buys or sells
+ FollowUndervalued by 105.6% based on the discounted cash flow analysis.
| Market cap | $7.90 Billion |
|---|---|
| Enterprise Value | $4.26 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.69 |
| Beta | 2.39 |
| Outstanding Shares | 302,220,000 |
| P/E Ratio | 17.82 |
|---|---|
| PEG | -6.89 |
| Price to Sales | 0.61 |
| Price to Book Ratio | 5.06 |
| Enterprise Value to Revenue | 0.28 |
| Enterprise Value to EBIT | 6.73 |
| Enterprise Value to Net Income | 7 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.21 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.8398▼ 23.32% |
|---|---|
| Total Calls | 13,279,400▲ 18.11% |
| Total Puts | 11,152,039▼ 7.56% |
Holdings and activity of institutional investors.
| Ownership % | 69.70%▲ 11.18% |
|---|---|
| Total Invested | $5.97B▲ 197.79% |
| Investors Holding | 441▲ 74.00% |
No data
Headquartered in New York City, Oscar has been challenging the health care s\stem's status quo since our founding in 2012. The compan\Ŗs member-ırst philosoph\ and innovative approach to care has earned us the trust of approxim...